Skip to main content
logo
G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
34.60
-0.95 (-2.67%)
Mar 4, 2026, 1:30 PM CST

G&E Herbal Biotechnology Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
2,2653,3393,4402,9721,5581,940
Market Cap Growth
-28.90%-2.92%15.73%90.71%-19.66%-3.19%
Enterprise Value
1,8553,0173,2262,8491,4461,819
Last Close Price
35.5551.6552.6745.5123.8629.70
PE Ratio
15.8632.7247.51402.69--
PS Ratio
7.2713.4118.9646.0163.4368.71
PB Ratio
2.514.014.514.302.282.76
P/TBV Ratio
2.954.775.475.342.843.42
P/FCF Ratio
13.6825.9431.8630.64--
P/OCF Ratio
13.3424.8030.3129.73-2515.89
EV/Sales Ratio
5.9512.1217.7844.1058.8364.44
EV/EBITDA Ratio
11.0323.3535.88191.43--
EV/EBIT Ratio
11.7725.2239.98519.39--
EV/FCF Ratio
11.2023.4429.8829.37--
Debt / Equity Ratio
0.000.000.00---
Debt / EBITDA Ratio
0.010.010.02---
Debt / FCF Ratio
0.010.010.02---
Net Debt / Equity Ratio
-0.46-0.49-0.41-0.30-0.16-0.17
Net Debt / EBITDA Ratio
-2.45-3.15-3.46-13.8410.6519.17
Net Debt / FCF Ratio
-2.48-3.16-2.88-2.129.9328.39
Asset Turnover
-0.270.220.090.040.04
Inventory Turnover
-1.961.551.140.811.07
Quick Ratio
6.613.422.772.2513.1415.04
Current Ratio
7.003.612.972.5415.6617.42
Return on Equity (ROE)
-12.78%9.96%1.07%-2.87%-2.01%
Return on Assets (ROA)
-8.12%6.05%0.46%-1.74%-1.34%
Return on Invested Capital (ROIC)
30.55%22.28%13.75%1.04%-3.38%-2.63%
Return on Capital Employed (ROCE)
17.50%14.30%10.60%0.80%-2.90%-2.20%
Earnings Yield
6.32%3.06%2.10%0.25%-1.28%-0.74%
FCF Yield
7.31%3.86%3.14%3.26%-0.70%-0.22%
Dividend Yield
1.95%1.36%0.95%---
Payout Ratio
31.21%31.12%----
Buyback Yield / Dilution
-0.05%-0.06%-0.08%---
Total Shareholder Return
1.86%1.30%0.86%---
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.